Correlation Between Estrella Immunopharma and Biora Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Biora Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Biora Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Estrella Immunopharma and Biora Therapeutics, you can compare the effects of market volatilities on Estrella Immunopharma and Biora Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Biora Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Biora Therapeutics.

Diversification Opportunities for Estrella Immunopharma and Biora Therapeutics

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Estrella and Biora is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Biora Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biora Therapeutics and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Biora Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biora Therapeutics has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Biora Therapeutics go up and down completely randomly.

Pair Corralation between Estrella Immunopharma and Biora Therapeutics

Assuming the 90 days horizon Estrella Immunopharma is expected to generate 0.09 times more return on investment than Biora Therapeutics. However, Estrella Immunopharma is 10.61 times less risky than Biora Therapeutics. It trades about -0.43 of its potential returns per unit of risk. Biora Therapeutics is currently generating about -0.4 per unit of risk. If you would invest  9.19  in Estrella Immunopharma on August 30, 2024 and sell it today you would lose (0.09) from holding Estrella Immunopharma or give up 0.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy17.39%
ValuesDaily Returns

Estrella Immunopharma  vs.  Biora Therapeutics

 Performance 
       Timeline  
Estrella Immunopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Estrella Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.
Biora Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biora Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Estrella Immunopharma and Biora Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Estrella Immunopharma and Biora Therapeutics

The main advantage of trading using opposite Estrella Immunopharma and Biora Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Biora Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biora Therapeutics will offset losses from the drop in Biora Therapeutics' long position.
The idea behind Estrella Immunopharma and Biora Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance